Boundless Bio, Inc.BOLDNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-58.4%
5Y CAGR-44.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-58.4%/yr
Annual compound
5Y CAGR
-44.4%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 3.93% |
| 2024 | 48.04% |
| 2023 | 30.60% |
| 2022 | 54.57% |
| 2021 | 0.00% |
| 2018 | 73.67% |
| 2017 | 53.20% |
| 2016 | 0.00% |